文献速递重症综合管理与镇静镇痛

持续性危重症发生的医院层面差异

Hospital-level variation in the development of persistent critical illness.
PubMed 文献 · Intensive Care Med · 2020-06-04
一句话结论在退伍军人事务部(VA)重症监护病房(ICU)中,风险与信度调整后30天死亡率较高的医院,患者发生持续性危重症的概率也较高(预测概率0.057 vs 0.046)。

该研究为2015至2017年退伍军人事务部(VA)ICU住院患者的回顾性分析,纳入100家医院共153,512例住院,持续性危重症定义为ICU住院时间至少11天。4.9%(7640/153,512)发生持续性危重症,控制患者特征后仍存在医院间差异(组内相关系数0.067,95%CI 0.049-0.091)。风险与信度调整后30天死亡率较高的医院,持续性危重症预测概率为0.057(95%CI 0.051-0.063,p<0.01),高于死亡率较低医院的0.046(95%CI 0.041-0.051,p<0.01);中位比值比1.4(95%CI 1.33-1.49),即入院生理状况相同的两名患者,入住调整死亡率较高医院者发生持续性危重症的 odds 高40%。作者认为,理解这种差异的驱动因素可能识别出可改变的因素。

要点

  • 持续性危重症定义为ICU住院时间至少11天,在100家VA医院153,512例住院中发生率为4.9%(7640/153,512)。
  • 控制患者特征后,持续性危重症的发生仍存在医院间差异,组内相关系数为0.067(95%CI 0.049-0.091)。
  • 风险与信度调整后30天死亡率较高的医院,持续性危重症预测概率为0.057(95%CI 0.051-0.063,p<0.01),高于死亡率较低医院的0.046(95%CI 0.041-0.051,p<0.01)。
  • 中位比值比1.4(95%CI 1.33-1.49):入院生理状况相同的两名患者,入住调整死亡率较高医院者发生持续性危重症的 odds 高40%。
  • 作者认为,理解这种差异的驱动因素可能识别出可改变的因素,从而影响持续性危重症的发生。

适用人群与场景

  • 2015至2017年入住退伍军人事务部(VA)ICU的退伍军人,共100家医院153,512例住院。

诊断标准与关键阈值

  • 持续性危重症定义为ICU住院时间至少11天。
  • 医院绩效定义为风险与信度调整后30天死亡率。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量:100家医院153,512例住院;人群:2015至2017年入住VA ICU的退伍军人。
  • 持续性危重症发生率为4.9%(N=7640/153,512)。
  • 控制患者特征后仍存在医院间差异,组内相关系数0.067(95%CI 0.049-0.091)。
  • 风险与信度调整后30天死亡率较高的医院,持续性危重症预测概率为0.057(95%CI 0.051-0.063,p<0.01);死亡率较低的医院为0.046(95%CI 0.041-0.051,p<0.01)。
  • 中位比值比1.4(95%CI 1.33-1.49):入院生理状况相同的两名患者,入住调整死亡率较高医院者发生持续性危重症的 odds 高40%。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,理解医院间持续性危重症发生差异的驱动因素可能识别出可改变的因素,从而影响持续性危重症的发生。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Patients with persistent critical illness may account for up to half of all intensive care unit (ICU) bed-days. It is unknown if there is hospital variation in the development of persistent critical illness and if hospital performance affects the incidence of persistent critical illness.

METHODS: This is a retrospective analysis of Veterans admitted to the Veterans Administration (VA) ICUs from 2015 to 2017. Hospital performance was defined by the risk- and reliability-adjusted 30-day mortality. Persistent critical illness was defined as an ICU length of stay of at least 11 days. We used 2-level multilevel logistic regression models to assess variation in risk- and reliability-adjusted probabilities in the development of persistent critical illness.

RESULTS: In the analysis of 100 hospitals which encompassed 153,512 hospitalizations, 4.9% (N = 7640/153,512) developed persistent critical illness. There was variation in the development of persistent critical illness despite controlling for patient characteristics (intraclass correlation: 0.067, 95% CI 0.049-0.091). Hospitals with higher risk- and reliability-adjusted 30-day mortality had higher probabilities of developing persistent critical illness (predicted probability: 0.057, 95% CI 0.051-0.063, p < 0.01) compared to those with lower risk- and reliability-adjusted 30-day mortality (predicted probability: 0.046, 95% CI 0.041-0.051, p < 0.01). The median odds ratio was 1.4 (95% CI 1.33-1.49) implying that, for two patients with the same physiology on admission at two different VA hospitals, the patient admitted to the hospital with higher adjusted mortality would have 40% greater odds of developing persistent critical illness.

CONCLUSION: Hospitals with higher risk- and reliability-adjusted 30-day mortality have a higher probability of developing persistent critical illness. Understanding the drivers of this variation may identify modifiable factors contributing to the development of persistent critical illness.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Viglianti EM, Bagshaw SM, Bellomo R, et al. Hospital-level variation in the development of persistent critical illness. Intensive Care Med. 2020. PMID: 32500182. doi:10.1007/s00134-020-06129-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。